Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis

B-cell chronic lymphocytic leukemia (B-CLL) cells are resistant to apoptosis, and consequently accumulate to the detriment of normal B cells and patient immunity. Because current therapies fail to eradicate these apoptosis-resistant cells, it is essential to identify alternative survival pathways as...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncogene
Autors principals: Abbaci, A, Talbot, H, Saada, S, Gachard, N, Abraham, J, Jaccard, A, Bordessoule, D, Fauchais, A L, Naves, T, Jauberteau, M O
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808079/
https://ncbi.nlm.nih.gov/pubmed/29059151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.365
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars